0001209191-11-033934.txt : 20110609
0001209191-11-033934.hdr.sgml : 20110609
20110609190902
ACCESSION NUMBER: 0001209191-11-033934
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110607
FILED AS OF DATE: 20110609
DATE AS OF CHANGE: 20110609
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: QUIDEL CORP /DE/
CENTRAL INDEX KEY: 0000353569
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 942573850
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10165 MCKELLAR CT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8585521100
FORMER COMPANY:
FORMER CONFORMED NAME: MONOCLONAL ANTIBODIES INC /DE/
DATE OF NAME CHANGE: 19910210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BRYANT DOUGLAS C
CENTRAL INDEX KEY: 0001406652
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-10961
FILM NUMBER: 11904109
MAIL ADDRESS:
STREET 1: LUMINEX CORPORATION
STREET 2: 12212 TECHNOLOGY BOULEVARD
CITY: AUSTIN
STATE: TX
ZIP: 78727
4
1
doc4.xml
FORM 4 SUBMISSION
X0303
4
2011-06-07
0
0000353569
QUIDEL CORP /DE/
QDEL
0001406652
BRYANT DOUGLAS C
10165 MCKELLAR COURT
SAN DIEGO
CA
92121
1
1
0
0
President & CEO
Common Stock
2011-06-07
4
P
0
5000
14.964
A
169396
D
Common Stock
2011-06-08
4
P
0
5000
15.177
A
174396
D
The weighted average purchase price for these transactions was $14.964 per share, with a range of $14.80 to $15.159 per share. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares purchased at each separate price.
The weighted average purchase price for these transactions was $15.177 per share, with a range of $15.14 to $15.189 per share. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares purchased at each separate price.
Robert J. Bujarski, attorney-in-fact for Doulgas C. Bryant
2011-06-09